PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Internal Medicine, New York University Grossman School of Medicine, New York, New York, USA.\', \'Colton Center for Autoimmunity, Department of Medicine and Pathology, New York University School of Medicine, New York, New York, USA.\', \'Rheumatology/Medicine, New York University Grossman School of Medicine, New York, New York, USA.\', \'Montreal Heart Institute, Montreal, Québec, Canada.\', \'Cardiology/Medicine, New York University Grossman School of Medicine, New York, New York, USA.\', \'Cardiology/Medicine, VA New York Harbor Healthcare System, New York, New York, USA.\', \'Rheumatology/Medicine, New York University Grossman School of Medicine, New York, New York, USA Michael.Pillinger@nyulangone.org.\', \'Rheumatology/Medicine, VA New York Harbor Healthcare System, New York, New York, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1136/annrheumdis-2020-219174
?:hasPublicationType
?:journal
  • Annals of the rheumatic diseases
is ?:pmid of
?:pmid
?:pmid
  • 33293273
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 7.699
?:rankingScore_hIndex
  • 198
?:title
  • Anti-inflammatory therapy for COVID-19 infection: the case for colchicine.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33293273>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33293273>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all